- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04548986
Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM) (OBPM_ABPM2020)
January 23, 2023 updated by: Cyril Pellaton
This study aims to assess the performances of optical blood pressure monitoring device, Aktiia.product in the context of cardiac rehabilitation program.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Neuchâtel, Switzerland, 2000
- Réseau Hospitalier Neuchâtelois
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult subjects (aged between 21 and 65)
- Subjects fluent in written and spoken French
- Subjects enrolled in a 12-weeks cardiac rehabilitation program
- Subjects agreeing to participate
- Subjects that have signed the informed consent form
Exclusion Criteria:
- Subjects with tachycardia (heart rate at rest > 120bpm)
- Subjects with atrial fibrillation
- Subjects with severe heart failure (LVEF<35%)
- Subjects with severe renal dysfunctions (eGFR < 30mL/min/1.73 m2)
- Subjects with pheochromocytoma
- Subjects with Raynaud's disease
- Subjects with trembling and shivering
- Subjects with interarm systolic difference > 15 mmHg
- Subjects with interarm diastolic difference > 10 mmHg
- Subjects with arm paralysis
- Women in known pregnancy
- Subjects with an arteriovenous fistula
- Subjects with arm amputations
- Subjects with the upper arm circumference > 64 cm
- Subjects with the wrist circumference > 22 cm
- Subjects with the exfoliative skin diseases
- Subjects with lymphoedema
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: single arm
single arm study
|
The participants wear Aktiia.bracelet
for the duration of the cardiac rehabilitation program.
The device is initialized once per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean absolute error for blood pressure
Time Frame: up to 24 hours
|
The mean absolute error between the Reference (standard ambulatory blood pressure monitor) and Aktiia.product
for systolic (SYS) and diastolic (DIA) blood pressure in mmHg
|
up to 24 hours
|
|
Mean error for blood pressure
Time Frame: up to 24 hours
|
The mean error between the Reference and Aktiia.product
for SYS and DIA in mmHg
|
up to 24 hours
|
|
Standard deviation of the error for blood pressure
Time Frame: up to 24 hours
|
The standard deviation of the error between Reference and Aktiia.product
for SYS and DIA in mmHg
|
up to 24 hours
|
|
Mean absolute error for heart rate
Time Frame: up to 24 hours
|
The mean absolute error between the Reference (standard ambulatory blood pressure monitor) and Aktiia.product
for heart rate in bpm
|
up to 24 hours
|
|
Mean error for heart rate
Time Frame: up to 24 hours
|
The mean error between the Reference and Aktiia.product
for heart rate in bpm
|
up to 24 hours
|
|
Standard deviation of the error for heart rate
Time Frame: up to 24 hours
|
The standard deviation of the error between Reference and Aktiia.product
for heart rate in bpm
|
up to 24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the impact of ABPM induced stress on BP readings using inferential statistics.
Time Frame: 1 week
|
Aktiia values acquired during the first day (with ABPM) will be compared to values acquired during other days of the week and a t-test will be performed.
The analysis will be repeated for night values.
|
1 week
|
|
Evaluation of patient's satisfaction for the two devices through a survey with multiple questions
Time Frame: up to 24 hours
|
10-points likert scale survey, an agree-disagree scale with minimum 0 and maximum 10.
Minimum value means strong disagreement, maximum value means strong agreement.
|
up to 24 hours
|
|
Assessment of the calibration stability of Aktiia OBPM algorithms
Time Frame: 12 weeks
|
Use different calibration points going from 1 to 12 weeks
|
12 weeks
|
|
Assessment of systolic and diastolic blood pressure control during a 12 weeks cardiac rehabilitation program
Time Frame: 12 weeks
|
comparison of blood pressure determinations taken at the beginning and at the end of the program in ambulatory settings
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 6, 2020
Primary Completion (Actual)
December 23, 2022
Study Completion (Actual)
December 23, 2022
Study Registration Dates
First Submitted
August 26, 2020
First Submitted That Met QC Criteria
September 11, 2020
First Posted (Actual)
September 16, 2020
Study Record Updates
Last Update Posted (Estimate)
January 25, 2023
Last Update Submitted That Met QC Criteria
January 23, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OBPM_ABPM2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Aktiia.product
-
Aktiia SARecruitingHypertension | Blood Pressure | Heart RateSwitzerland
-
Aktiia SAUniversity of Lausanne HospitalsRecruitingBlood PressureSwitzerland